tulathromycin and its Impurities

Tulathromycin is used to treat bovine respiratory disease in cattle and swine respiratory disease in pigs. It is a macrolide antibiotic. It is marketed by Pfizer Inc under the tradename Draxxin.Reference standards of Tulathromycin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 14 results for tulathromycin Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 20 78000

Tulathromycin

Tulathromycin


  • Catalogue No.:PA 20 78000

  • CAS :

    217500-96-4

  • Molecular Formula : C41H79N3O12

  • Molecular Weight : 806.08

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781000

Tulathromycin B, approximately 5% (As a mixture with Tulathromycin A)

Tulathromycin B, approximately 5% (As a mixture with Tulathromycin A)


  • Catalogue No.:PA 20 0781000

  • CAS :

    280755-12-6

  • Molecular Formula : C41H79N3O12

  • Molecular Weight : 806.09

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781001

Benzyl ((2S,3R,4S,6R)-4-(Dimethylamino)-2-(((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((3S,4S,6R,8R)-8-methoxy-4,8-dimethyl-1,5-dioxaspiro[2.5]octan-6-yl)oxy)-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadecan-11-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl) carbonate

Benzyl ((2S,3R,4S,6R)-4-(Dimethylamino)-2-(((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((3S,4S,6R,8R)-8-methoxy-4,8-dimethyl-1,5-dioxaspiro[2.5]octan-6-yl)oxy)-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadecan-11-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl) carbonate


  • Catalogue No.:PA 20 0781001

  • CAS :

    217649-77-9

  • Molecular Formula : C46H76N2O14

  • Molecular Weight : 881.11

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781002

Benzyl ((2S,3S,4S,6S)-4-(dimethylamino)-2-(((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-((propylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadecan-11-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl) carbonate hydrate

Benzyl ((2S,3S,4S,6S)-4-(dimethylamino)-2-(((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-((propylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadecan-11-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl) carbonate hydrate


  • Catalogue No.:PA 20 0781002

  • CAS :

    NA

  • Molecular Formula : C49H87N3O15

  • Molecular Weight : 958.24

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781003

Tulathromycin N-Oxide

Tulathromycin N-Oxide


  • Catalogue No.:PA 20 0781003

  • CAS :

    NA

  • Molecular Formula : C41H79N3O13

  • Molecular Weight : 822.09

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781004

(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-(((2R,4R,5S,6S)-5-(aminomethyl)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one

(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-(((2R,4R,5S,6S)-5-(aminomethyl)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-11-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one


  • Catalogue No.:PA 20 0781004

  • CAS :

    371193-60-1

  • Molecular Formula : C38H73N3O12

  • Molecular Weight : 764.01

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781005

(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-13-(((5S,6S,8R,10R)-10-methoxy-6,10-dimethyl-3-propyl-1,7-dioxa-3-azaspiro[4.5]decan-8-yl)oxy)-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one

(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-13-(((5S,6S,8R,10R)-10-methoxy-6,10-dimethyl-3-propyl-1,7-dioxa-3-azaspiro[4.5]decan-8-yl)oxy)-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one


  • Catalogue No.:PA 20 0781005

  • CAS :

    352032-81-6

  • Molecular Formula : C42H79N3O12

  • Molecular Weight : 818.1

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781006

Tulathromycin A Diastereomer

Tulathromycin A Diastereomer


  • Catalogue No.:PA 20 0781006

  • CAS :

    217500-34-0

  • Molecular Formula : C41H79N3O12

  • Molecular Weight : 806.09

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781007

(3R,6R,8R,9R,10S,11S,12R)-2-((2R,3R)-2,3-Dihydroxypentan-2-yl)-9-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-hydroxy-11-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-((propylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-3,6,8,10,12-pentamethyl-1-oxa-4-azacyclotridecan-13-one

(3R,6R,8R,9R,10S,11S,12R)-2-((2R,3R)-2,3-Dihydroxypentan-2-yl)-9-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-hydroxy-11-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-((propylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-3,6,8,10,12-pentamethyl-1-oxa-4-azacyclotridecan-13-one


  • Catalogue No.:PA 20 0781007

  • CAS :

    352032-76-9

  • Molecular Formula : C41H79N3O12

  • Molecular Weight : 806.09

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781008

(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-13-(((5S,6S,8R,10R)-10-methoxy-2,2,6,10-tetramethyl-3-propyl-1,7-dioxa-3-azaspiro[4.5]decan-8-yl)oxy)-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one

(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-13-(((5S,6S,8R,10R)-10-methoxy-2,2,6,10-tetramethyl-3-propyl-1,7-dioxa-3-azaspiro[4.5]decan-8-yl)oxy)-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one


  • Catalogue No.:PA 20 0781008

  • CAS :

    NA

  • Molecular Formula : C44H83N3O12

  • Molecular Weight : 846.16

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781009

(2R,3R,4S,5R,8R,10R,11R,12S,13S,14R)-11-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-4,10-dihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-((propylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one

(2R,3R,4S,5R,8R,10R,11R,12S,13S,14R)-11-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-4,10-dihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-((propylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one


  • Catalogue No.:PA 20 0781009

  • CAS :

    NA

  • Molecular Formula : C41H79N3O11

  • Molecular Weight : 790.09

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781010

(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-((propylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-11-(((2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one

(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-((propylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-11-(((2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one


  • Catalogue No.:PA 20 0781010

  • CAS :

    2051579-12-3

  • Molecular Formula : C40H77N3O12

  • Molecular Weight : 792.07

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781011

(1S,2R,3R,6R,7S,8S,9R,10R,12R,16S)-9-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3-ethyl-2,10-dihydroxy-7-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2,6,8,10,12,16-hexamethyl-4,15-dioxa-14-azabicyclo[11.2.1]hexadec-13-en-5-one

(1S,2R,3R,6R,7S,8S,9R,10R,12R,16S)-9-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-3-ethyl-2,10-dihydroxy-7-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2,6,8,10,12,16-hexamethyl-4,15-dioxa-14-azabicyclo[11.2.1]hexadec-13-en-5-one


  • Catalogue No.:PA 20 0781011

  • CAS :

    NA

  • Molecular Formula : C37H66N2O12

  • Molecular Weight : 730.94

Drug Reference Standards & Impurity Synthesis in India
PA 20 0781012

N-((2S,3R,4S,6R)-2-(((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-((propylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadecan-11-yl)oxy)-3-hydroxy-6-methyltetrahydro-2H-pyran-4-yl)-N-methylformamide

N-((2S,3R,4S,6R)-2-(((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-((propylamino)methyl)tetrahydro-2H-pyran-2-yl)oxy)-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-azacyclopentadecan-11-yl)oxy)-3-hydroxy-6-methyltetrahydro-2H-pyran-4-yl)-N-methylformamide


  • Catalogue No.:PA 20 0781012

  • CAS :

    NA

  • Molecular Formula : C41H77N3O13

  • Molecular Weight : 820.08

pharmaffiliates